Back to Authors

Lv, Huiying

Mayo Clinic

Shanghai Jiao Tong University

Citations 1

Contribution of Staphylococcal Enterotoxin B toStaphylococcus aureusSystemic Infection
Bae, Justin S. , Liu, Ryan , He, Lei , Lv, Huiying, Fisher, Emilie L. , Rajagopalan, Govindarajan , Li, Min , Cheung, Gordon Y. C. , Otto, Michaƫl , Otto, Michael , Da, Fei , Li, Min

The Journal of Infectious Diseases | September 14, 2020 | Volume: 223 | Issue: 10 | Pages: 1766-1775

10.1093/infdis/jiaa584 Get It

AbstractStaphylococcal enterotoxin B (SEB), which is produced by the major human pathogen, Staphylococcus aureus, represents a powerful superantigenic toxin and is considered a bioweapon. However, the contribution of SEB to S. aureus pathogenesis has never been directly demonstrated with genetically defined mutants in clinically relevant strains. Many isolates of the predominant Asian community-associated methicillin-resistant S. aureus lineage sequence type (ST) 59 harbor seb, implying a significant role of SEB in the observed hypervirulence of this lineage. We created an isogenic seb mutant in a representative ST59 isolate and assessed its virulence potential in mouse infection models. We detected a significant contribution of seb to systemic ST59 infection that was associated with a cytokine storm. Our results directly demonstrate that seb contributes to S. aureus pathogenesis, suggesting the value of including SEB as a target in multipronged antistaphylococcal drug development strategies. Furthermore, they indicate that seb contributes to fatal exacerbation of community-associated methicillin-resistant S. aureus infection.